Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.

Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2013 Feb; 45(2):159-69.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.